- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 14, 2025 | 2.48M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.01M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $951.73K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.14M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $2.78M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $4.08M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $3.03M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.1M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $4.17M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.38M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $5.41M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.54M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $4.67M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $6.63M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $8.6M |
| Stock Issued | Q1 2025 · Dec 6, 2024 | 139K sh |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 674.13K sh |
| Capex | Q1 2025 · Mar 31, 2024 | $2.78K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$2.16M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$3.97 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$3.97 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $2.49M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $451.84K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$2.68M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$2.85M |
| Revenue | Q1 2025 · Mar 31, 2024 | $573.68K |